Dashboard
1
With a growth in Operating Profit of 99.39%, the company declared Very Positive results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 209.12 MM
- PRE-TAX PROFIT(Q) At CNY 32.7 MM has Grown at 461.64%
- DEBT-EQUITY RATIO (HY) Lowest at -35.8 %
2
With ROE of -0.96%, it has a risky valuation with a 1.52 Price to Book Value
3
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,429 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.38
-1.07%
1.59
Revenue and Profits:
Net Sales:
171 Million
(Quarterly Results - Mar 2026)
Net Profit:
64 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.67%
0%
-7.67%
6 Months
-3.6%
0%
-3.6%
1 Year
71.09%
0%
71.09%
2 Years
8.57%
0%
8.57%
3 Years
-3.73%
0%
-3.73%
4 Years
-43.64%
0%
-43.64%
5 Years
-72.57%
0%
-72.57%
Shanghai Kinetic Medical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.38%
EBIT Growth (5y)
-171.16%
EBIT to Interest (avg)
5.87
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.32
Tax Ratio
14.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.97%
ROE (avg)
3.92%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.52
EV to EBIT
-70.93
EV to EBITDA
82.60
EV to Capital Employed
1.81
EV to Sales
3.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.55%
ROE (Latest)
-0.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
171.00
175.10
-2.34%
Operating Profit (PBDIT) excl Other Income
23.50
12.40
89.52%
Interest
0.00
0.30
-100.00%
Exceptional Items
-2.80
49.20
-105.69%
Consolidate Net Profit
64.40
60.00
7.33%
Operating Profit Margin (Excl OI)
137.40%
-44.20%
18.16%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.34% vs -27.61% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 7.33% vs 119.78% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
959.60
979.00
-1.98%
Operating Profit (PBDIT) excl Other Income
142.50
163.10
-12.63%
Interest
10.70
10.00
7.00%
Exceptional Items
56.70
-195.40
129.02%
Consolidate Net Profit
131.60
-96.20
236.80%
Operating Profit Margin (Excl OI)
63.50%
82.40%
-1.89%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.98% vs 3.13% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 236.80% vs -175.99% in Dec 2024
About Shanghai Kinetic Medical Co., Ltd. 
Shanghai Kinetic Medical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






